Free access to emergency oral contraceptives (EOCs) in the European Union: A regulatory vacuum to be filled.

Pub Date : 2023-01-01 DOI:10.3233/JRS-220011
Andrea Cioffi, Camilla Cecannecchia, Fernanda Cioffi, Raffaella Rinaldi, Giorgio Bolino
{"title":"Free access to emergency oral contraceptives (EOCs) in the European Union: A regulatory vacuum to be filled.","authors":"Andrea Cioffi,&nbsp;Camilla Cecannecchia,&nbsp;Fernanda Cioffi,&nbsp;Raffaella Rinaldi,&nbsp;Giorgio Bolino","doi":"10.3233/JRS-220011","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>According to the World Health Organization (WHO), any woman in childbearing age who have decided not to take permanently an oral contraceptive but who are sexually active has the right to access emergency contraception (EC). Despite this, in many European countries there are no specific laws governing the criteria for access to emergency oral contraceptives (EOCs) for girls under 18, especially about the need for third party consent. This normative vacuum is dangerous as it risks creating confusion and entrusting the management of the fundamental right of self-determination to the discretion of others. Moreover, in European Union (EU) countries, there is an inequality in terms of access to contraceptive supplies, reimbursement criteria and the availability of information online.</p><p><strong>Objective: </strong>Our article compares the criteria for access to EOCs (Ulipristal Acetate-UPA and Levonorgestrel-LNG) in the various EU countries to highlight possible disparities and consequent inequalities.</p><p><strong>Methods: </strong>Government and ministerial websites, European agencies websites, and Contraceptive Use by Method 2019 (WHO) have been consulted.</p><p><strong>Results: </strong>There are some differences between the various European countries that could configure inequality in EU countries.</p><p><strong>Conclusions: </strong>It would be appropriate a definitive levelling of the legislation of the European Union on emergency contraception associated with massive information and awareness campaigns.</p>","PeriodicalId":0,"journal":{"name":"","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.3233/JRS-220011","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 1

Abstract

Background: According to the World Health Organization (WHO), any woman in childbearing age who have decided not to take permanently an oral contraceptive but who are sexually active has the right to access emergency contraception (EC). Despite this, in many European countries there are no specific laws governing the criteria for access to emergency oral contraceptives (EOCs) for girls under 18, especially about the need for third party consent. This normative vacuum is dangerous as it risks creating confusion and entrusting the management of the fundamental right of self-determination to the discretion of others. Moreover, in European Union (EU) countries, there is an inequality in terms of access to contraceptive supplies, reimbursement criteria and the availability of information online.

Objective: Our article compares the criteria for access to EOCs (Ulipristal Acetate-UPA and Levonorgestrel-LNG) in the various EU countries to highlight possible disparities and consequent inequalities.

Methods: Government and ministerial websites, European agencies websites, and Contraceptive Use by Method 2019 (WHO) have been consulted.

Results: There are some differences between the various European countries that could configure inequality in EU countries.

Conclusions: It would be appropriate a definitive levelling of the legislation of the European Union on emergency contraception associated with massive information and awareness campaigns.

分享
查看原文
在欧洲联盟免费获得紧急口服避孕药:有待填补的监管真空。
背景:根据世界卫生组织(世卫组织)的规定,任何已决定不长期服用口服避孕药但性活跃的育龄妇女都有权获得紧急避孕药(EC)。尽管如此,在许多欧洲国家,没有具体法律规定18岁以下女孩获得紧急口服避孕药的标准,特别是关于需要第三方同意的标准。这种规范真空是危险的,因为它有可能造成混乱,并将管理基本自决权利的工作委托给他人。此外,在欧洲联盟(欧盟)国家,在获得避孕用品、偿还标准和获得网上信息方面存在不平等。目的:我们的文章比较了不同欧盟国家获得EOCs(醋酸乌普利司特- upa和左炔诺孕酮- lng)的标准,以突出可能的差异和随之而来的不平等。方法:咨询了政府和部委网站、欧洲机构网站以及《2019年避孕方法使用》(世卫组织)。结果:欧洲各国之间存在一些差异,这些差异可能会导致欧盟国家的不平等。结论:在开展大规模宣传和提高认识运动的同时,明确调整欧洲联盟关于紧急避孕的立法是适当的。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信